History of glucagon-like peptide-1 receptor agonists
Year: 2025
Type: article
Abstract: • GLP-1RA development traces a century of translational progress from gut hormones to multi-agonist therapeutics. • Rational protein engineering and delivery innovations transformed incretin biology into global metabolic therapeutics. • Modern dual and triple agonists achieve surgical-level metabolic benefits, redefining diabetes and obesity care.
Source: Pharmacological Research
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $4,130
OpenAlex ID: W4416827144
